Skip to main navigation Skip to search Skip to main content

Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19

  • Mohamad Shebley
  • , Stanley Wang
  • , Izna Ali
  • , Preethi Krishnan
  • , Rakesh Tripathi
  • , Joseph M. Reardon
  • , John Cafardi
  • , Galia Rahav
  • , Yoseph Caraco
  • , Jihad Slim
  • , Fadi Al Akhrass
  • , Mengjia Yu
  • , Yiran Hu
  • , Rosa De Abreu Ferreira
  • , Negar N. Alami

Tel Aviv University

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases